1st Quarter - Report

BROWNSTEIN HYATT FARBER SCHRECK, LLP for ELI LILLY AND COMPANY

Firm
Client
Income
$50,000
Expenses
—

What was lobbied

2 issue areas, each in the filer's own words, with who lobbied on it and where.

Pharmacy PHA

Issues related to the pharmaceutical industry HR 748 CARES Act - Issues related to COVID-19 relief

LobbyistCovered position, as disclosed
NADEAM ELSHAMI —
MARC LAMPKIN —
BRIAN MCKEON —
WILLIAM MOSCHELLA New PrincAssocDepAG DOJ,AsstAG DOJ,ChfLegCouns/Parliam Hs Judic Comm,ChfInvestigativeCouns Hs Judic Comm,GC Hs Rules Comm,Couns Hs Judic Comm,Couns/Parliam Hs Gov Rel Comm,SrLegAsst Rep Frank Wolf,LegAsst RepFrank Wolf,ComputerSysManager Rep Frank Wolf
ZACHARY PFISTER —
BRIAN WILD —

Contacted: SENATE; Health & Human Services, Dept of (HHS); Office of the Vice President of the United States; Natl Economic Council (NEC); HOUSE OF REPRESENTATIVES; Executive Office of the President (EOP)

Bills named: H.R. 748 (116th)

Medical/Disease Research/Clinical Labs MED

Issues related to the pharmaceutical industry

LobbyistCovered position, as disclosed
EMILY FELDER —

Contacted: Office of the Vice President of the United States; Health & Human Services, Dept of (HHS); Natl Economic Council (NEC); SENATE; Executive Office of the President (EOP); HOUSE OF REPRESENTATIVES

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.